Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
出版年份 2021 全文链接
标题
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
作者
关键词
-
出版物
Cell Reports
Volume 36, Issue 8, Pages 109604
出版商
Elsevier BV
发表日期
2021-08-10
DOI
10.1016/j.celrep.2021.109604
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
- (2021) Elizabeth M. Anderson et al. CELL
- Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
- (2021) Dami A. Collier et al. NATURE
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
- (2021) Zijun Wang et al. NATURE
- Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
- (2021) Rita E. Chen et al. NATURE MEDICINE
- Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses
- (2021) Maryam Mukhamedova et al. IMMUNITY
- Structural Basis for a Convergent Immune Response against Ebola Virus
- (2020) Hadas Cohen-Dvashi et al. Cell Host & Microbe
- Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
- (2020) Yushun Wan et al. JOURNAL OF VIROLOGY
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
- (2020) Meng Yuan et al. SCIENCE
- Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
- (2020) Shibo Jiang et al. TRENDS IN IMMUNOLOGY
- TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
- (2020) Ruochen Zang et al. Science Immunology
- PyIR: a scalable wrapper for processing billions of immunoglobulin and T cell receptor sequences using IgBLAST
- (2020) Cinque Soto et al. BMC BIOINFORMATICS
- Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
- (2020) Christoph Kreer et al. CELL
- Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
- (2020) Yunlong Cao et al. CELL
- Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2
- (2020) James Brett Case et al. Cell Host & Microbe
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
- (2020) Lihong Liu et al. NATURE
- Potently neutralizing and protective human antibodies against SARS-CoV-2
- (2020) Seth J. Zost et al. NATURE
- Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
- (2020) Seth J. Zost et al. NATURE MEDICINE
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- (2020) Thomas F. Rogers et al. SCIENCE
- Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
- (2020) Johanna Hansen et al. SCIENCE
- Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
- (2020) Philip J. M. Brouwer et al. SCIENCE
- Broad neutralization of SARS-related viruses by human monoclonal antibodies
- (2020) Anna Z. Wec et al. SCIENCE
- Structural basis of a shared antibody response to SARS-CoV-2
- (2020) Meng Yuan et al. SCIENCE
- Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics
- (2020) Pavlo Gilchuk et al. Nature Biomedical Engineering
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- Spike mutation D614G alters SARS-CoV-2 fitness
- (2020) Jessica A. Plante et al. NATURE
- SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
- (2020) Emma S. Winkler et al. NATURE IMMUNOLOGY
- Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
- (2020) M. Alejandra Tortorici et al. SCIENCE
- Growth, detection, quantification, and inactivation of SARS-CoV-2
- (2020) James Brett Case et al. VIROLOGY
- Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak
- (2020) Adam S. Dingens et al. Nature Communications
- Topaz-Denoise: general deep denoising models for cryoEM and cryoET
- (2020) Tristan Bepler et al. Nature Communications
- Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease
- (2020) Joseph W. Golden et al. JCI Insight
- Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
- (2020) Allison J. Greaney et al. Cell Host & Microbe
- A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody
- (2020) Nicholas C. Wu et al. PLoS Pathogens
- Commonality despite exceptional diversity in the baseline human antibody repertoire
- (2019) Bryan Briney et al. NATURE
- High frequency of shared clonotypes in human B cell receptor repertoires
- (2019) Cinque Soto et al. NATURE
- Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection
- (2019) Carl W. Davis et al. CELL
- Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV
- (2019) Stefanie A. Ehrhardt et al. NATURE MEDICINE
- Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs
- (2019) Tristan Bepler et al. NATURE METHODS
- Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection
- (2018) Ian Setliff et al. Cell Host & Microbe
- cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
- (2017) Ali Punjani et al. NATURE METHODS
- Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses
- (2016) M. Gordon Joyce et al. CELL
- Enhancing dengue virus maturation using a stable furin over-expressing cell line
- (2016) Swati Mukherjee et al. VIROLOGY
- Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors
- (2015) Tongqing Zhou et al. CELL
- H5N1 Vaccine–Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem
- (2015) Adam K. Wheatley et al. JOURNAL OF IMMUNOLOGY
- Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells
- (2015) Jake Chng et al. mAbs
- Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies
- (2015) W. B. Williams et al. SCIENCE
- A high-throughput shotgun mutagenesis approach to mapping B-cell antibody epitopes
- (2014) Edgar Davidson et al. IMMUNOLOGY
- Rapid development of broadly influenza neutralizing antibodies through redundant mutations
- (2014) Leontios Pappas et al. NATURE
- Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
- (2012) E. Giang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Persistence of Circulating Memory B Cell Clones with Potential for Dengue Virus Disease Enhancement for Decades following Infection
- (2011) S. A. Smith et al. JOURNAL OF VIROLOGY
- Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
- (2011) X. Wu et al. SCIENCE
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
- (2009) Jianhua Sui et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started